A detailed history of Patient Capital Management, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Patient Capital Management, LLC holds 411,555 shares of ILMN stock, worth $56 Million. This represents 2.89% of its overall portfolio holdings.

Number of Shares
411,555
Previous 414,858 0.8%
Holding current value
$56 Million
Previous $43.3 Million 23.93%
% of portfolio
2.89%
Previous 2.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$105.28 - $135.9 $347,739 - $448,877
-3,303 Reduced 0.8%
411,555 $53.7 Million
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $17.1 Million - $22.6 Million
169,571 Added 69.13%
414,858 $43.3 Million
Q1 2024

May 15, 2024

BUY
$127.73 - $147.2 $588,707 - $678,444
4,609 Added 1.92%
245,287 $33.7 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $22.3 Million - $34.3 Million
240,678 New
240,678 $33.5 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Patient Capital Management, LLC Portfolio

Follow Patient Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patient Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patient Capital Management, LLC with notifications on news.